Sleep & Pineal Peptides

Pinealon (Glu-Asp-Arg)

For Research Use Only. Not for Human or Veterinary Use.

Overview

Pinealon is a synthetic tripeptide (Glu-Asp-Arg, EDR) studied as a pineal cytoprotective peptide. Where Epitalon is framed around telomerase and melatonin rhythm, Pinealon’s literature centres on protecting pinealocytes from oxidative stress, supporting circadian regulation and improving stress resistance. It is a research compound.

Chemical Profile

PropertyValue
CAS number292422-98-9
ClassSynthetic pineal tripeptide
Amino-acid sequenceH-Glu-Asp-Arg-OH
One-letter codeEDR (3 aa)
Molecular formulaC₁₅H₂₆N₆O₈
Molecular weight≈ 418.4 g/mol
Purity (HPLC)≥ 98%
AppearanceWhite to off-white lyophilized powder
Pinealon at a glance
Class
Synthetic pineal tripeptide
Sequence
Glu-Asp-Arg (EDR)
Research status
Preclinical and clinical (Eastern Europe)
Study routes
Subcutaneous (primary), intranasal
Half-life
≈ 20–40 min
Key feature
Pinealocyte protection; stress resistance

Mechanism of Action

Pinealon is a short peptide designed to reproduce the cytoprotective activity of endogenous pineal factors. Its studied mechanism centres on the pinealocyte: reducing reactive-oxygen-species production, supporting mitochondrial function and antioxidant enzymes, and limiting apoptosis — which is linked in the literature to circadian support and improved stress resistance.

ComponentDetail
Primary targetPinealocyte mitochondrial function
Oxidative stressReduced ROS; support for SOD and glutathione peroxidase
Anti-apoptoticStudied for caspase inhibition
AANATSupport for the melatonin-synthesis enzyme
HPA axisReported cortisol normalisation
Stress resistanceA prominent theme in Pinealon research

Pharmacology

ParameterValue
Half-life (t½)≈ 20–40 min
Bioavailability (SC)Moderate (short peptide)
MetabolismRapid proteolytic degradation
Route of administrationSubcutaneous, intranasal
EliminationRenal (amino acids / fragments)

Research Evidence

Representative studies and their focus are named below; specific numerical outcomes are not restated here as claims.

Study typeResearch focusReference
Pinealocyte / neuronal culturesOxidative-stress protectionPinealon preclinical literature
Rodent stress / hypoxia modelsStress resistance and neuroprotectionPinealon preclinical literature
Clinical aging observationCircadian and cognitive markersKhavinson VK, et al. (Eastern Europe)

Representative reported directions from the literature (qualitative; GLP-1 entries reflect published clinical-trial results, others are reported study directions, not restated as precise product claims):

Reported direction / findingContextReference
Pinealocyte protection from oxidative stresscell modelsPinealon literature
Stress-resistance and neuroprotective effectsrodent stress modelsPinealon literature

For laboratory research use only. Not for human or veterinary use, diagnosis, or therapeutic application. Descriptions refer to published research contexts and are not medical or product claims.

Dosing & Reconstitution Reference

Reconstitution and handling parameters for laboratory research. Not dosing guidance for human use.

ParameterReference value
Research dose range (literature)≈ 5–10 mg per cycle-day (SC), in study protocols
Reconstitution solventBacteriostatic water (0.9% benzyl alcohol)
Storage (lyophilized)−20°C, protected from light
Storage (reconstituted)2–8°C, up to ~1 week
Do not useIf the solution is cloudy or contains particulates

Safety Profile

Published research observations, provided for reference only. This material is not for human or veterinary use.

CategoryPublished observations
TolerabilityWell tolerated in reported studies
LocalMild injection-site reactions possible
CytotoxicityNo cytotoxicity reported
StatusFor research use only; not for human or veterinary application

Physicochemical Properties

PropertyValue
Physical stateWhite to off-white lyophilized powder
Solubility (water)Freely soluble
logP≈ −3.8 (very hydrophilic)
Isoelectric point (pI)≈ 6.5 (near neutral)
pH (reconstituted)5.0–6.5
Stability (lyophilized)≥ 24 months at −20°C

Synthesis & Manufacturing

Pinealon is a 3-residue peptide made by Fmoc solid-phase synthesis — a short, straightforward synthesis, purified by preparative HPLC to research grade.

StepDetail
StrategyFmoc solid-phase peptide synthesis
ResinWang resin (C-terminal acid)
CouplingHBTU / HOBt with DIPEA
CleavageTFA / TIPS / H₂O (95 : 2.5 : 2.5)
PurificationPreparative RP-HPLC (C18, TFA/ACN gradient)
  • Notes: coupling efficiency and complete Fmoc removal are monitored each cycle; hindered or repeated residues (e.g. Arg-Arg) may need double coupling.
  • Preparative RP-HPLC removes deletion and truncation impurities to reach research-grade purity; salt exchange (lyophilization from dilute HCl) removes residual TFA/acetate.
  • Critical quality attributes: correct molecular weight and low deletion-peptide content. A very short tripeptide; dissolves rapidly.

Analytical Methods

MethodParameterTypical result
RP-HPLC (C18, UV 214 nm)Purity≥ 98%
HPLC retentionC18, reversed-phase TFA/ACN gradientSingle main peak
ESI-MS (positive mode)Identity / mass[M+H]⁺ ≈ 419 Da
MALDI-TOFMass confirmation[M+H]⁺ ≈ 419 Da
Amino-acid analysisCompositionConsistent with the stated sequence
LC-MS (extracted ion)Deletion-peptide impuritiesWithin specification
Karl FischerWater content< 6%
LAL assayEndotoxinWithin specification
Ion chromatographyResidual TFA< 500 ppm

Representative RP-HPLC purity method:

  • Column: C18, 5 µm, 250 × 4.6 mm
  • Mobile phase A: 0.1% TFA in water · Mobile phase B: 0.1% TFA in acetonitrile
  • Gradient: reversed-phase TFA/ACN gradient · Flow rate: 1.0 mL/min · Detection: UV 214 nm
  • Confirmatory LC-MS: ESI positive mode ([M+H]⁺ ≈ 419 Da). A very short tripeptide; dissolves rapidly.

Stability Data

Representative stability behaviour under common storage, handling and formulation conditions.

ConditionDurationResult
Lyophilized, −20°C, dark≥ 24 monthsNo significant degradation (purity > 97%)
Lyophilized, 2–8°C, dark≥ 12 monthsMinimal degradation (purity > 95%)
Lyophilized, 25°C (accelerated)3 months< 5% degradation
Reconstituted, 2–8°C, dark7–14 daysMinor degradation
Reconstituted, 25°C24–48 hUse promptly
Light exposure (ICH Q1B)1.2 M lux·hGenerally light-stable
Freeze–thaw (−20°C ⇄ 25°C)3 cyclesAcceptable — aliquot to avoid repeats
  • Keep lyophilized powder cold, dry and light-protected; keep any solution refrigerated and protected from light.
  • Minimise freeze-thaw cycles; aliquot material used across many sessions.
  • Key factor: A very short tripeptide; dissolves rapidly.

Selected References

  • Khavinson VK, et al. Short peptides and pineal / pinealocyte regulation (Pinealon literature).
  • Reviews of pineal regulatory peptides and cytoprotection.

Quality & Supply

  • HPLC ≥ 98% purity with a Certificate of Analysis per batch
  • Identity confirmed by LC-MS
  • Research samples through to bulk, with worldwide delivery
  • Custom quantities and packaging on request

Need Pinealon — sample or bulk?

HPLC-verified, COA per batch. Tell us the quantity you need.

Request a Quote